Pathricia V. Tilstam

792 total citations
19 papers, 563 citations indexed

About

Pathricia V. Tilstam is a scholar working on Immunology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pathricia V. Tilstam has authored 19 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pathricia V. Tilstam's work include Macrophage Migration Inhibitory Factor (11 papers), Nuclear Receptors and Signaling (5 papers) and Cell Adhesion Molecules Research (3 papers). Pathricia V. Tilstam is often cited by papers focused on Macrophage Migration Inhibitory Factor (11 papers), Nuclear Receptors and Signaling (5 papers) and Cell Adhesion Molecules Research (3 papers). Pathricia V. Tilstam collaborates with scholars based in United States, Germany and Netherlands. Pathricia V. Tilstam's co-authors include Richard Bucala, Edward Doherty, Lin Leng, Jürgen Bernhagen, Lawrence H. Young, Dake Qi, Heidi Noels, Christian Weber, Maor Sauler and Wendy Theelen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Pathricia V. Tilstam

19 papers receiving 560 citations

Peers

Pathricia V. Tilstam
Alexandra C Finney United States
Patrick Albert United States
Nagadhara Dronadula United States
Zakar Mnjoyan United States
Alun R. Wang United States
Pathricia V. Tilstam
Citations per year, relative to Pathricia V. Tilstam Pathricia V. Tilstam (= 1×) peers Judith Alonso

Countries citing papers authored by Pathricia V. Tilstam

Since Specialization
Citations

This map shows the geographic impact of Pathricia V. Tilstam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pathricia V. Tilstam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pathricia V. Tilstam more than expected).

Fields of papers citing papers by Pathricia V. Tilstam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pathricia V. Tilstam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pathricia V. Tilstam. The network helps show where Pathricia V. Tilstam may publish in the future.

Co-authorship network of co-authors of Pathricia V. Tilstam

This figure shows the co-authorship network connecting the top 25 collaborators of Pathricia V. Tilstam. A scholar is included among the top collaborators of Pathricia V. Tilstam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pathricia V. Tilstam. Pathricia V. Tilstam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kim, Bong‐Sung, Pathricia V. Tilstam, Lin Leng, et al.. (2020). Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF‐2 in adipose tissue during endotoxemia. The FASEB Journal. 34(3). 4219–4233. 28 indexed citations
2.
ElGindi, Mei, et al.. (2019). Elucidating the role of an immunomodulatory protein in cancer: From protein expression to functional characterization. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 307–360. 13 indexed citations
3.
Tilstam, Pathricia V., Josefin Soppert, Yvonne Döring, et al.. (2019). Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice. Atherosclerosis. 292. 23–30. 3 indexed citations
4.
Doherty, Edward, et al.. (2019). Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opinion on Therapeutic Targets. 23(9). 733–744. 109 indexed citations
5.
Tilstam, Pathricia V., Wibke Schulte, Thomas Holowka, et al.. (2019). Selective Recruitment of Lethal Pro-inflammatory Macrophages in Sepsis by MIF but not D-DT (MIF-2). The Journal of Immunology. 202(1_Supplement). 51.9–51.9. 1 indexed citations
6.
Tilstam, Pathricia V., Georgios Pantouris, Michael L. Corman, et al.. (2019). A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity. Journal of Biological Chemistry. 294(49). 18522–18531. 29 indexed citations
7.
Doherty, Edward, Pathricia V. Tilstam, & Richard Bucala. (2019). MIF and MIF2 have distinct but synergistic roles in CIA pathogenesis. The Journal of Immunology. 202(1_Supplement). 180.13–180.13. 1 indexed citations
8.
Kim, Hee Kyung, Alvaro Baeza Garcia, Pathricia V. Tilstam, et al.. (2019). Macrophage migration inhibitory factor regulates innate γδ T‐cell responses via IL‐17 expression. The FASEB Journal. 33(6). 6919–6932. 7 indexed citations
9.
Schmitz, Corinna, Heidi Noels, Omar El Bounkari, et al.. (2018). Mif ‐deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. The FASEB Journal. 32(8). 4428–4443. 22 indexed citations
10.
Sauler, Maor, Yue Hou, Jonathan Merola, et al.. (2018). Endothelial cell‐secreted MIF reduces pericyte contractility and enhances neutrophil extravasation. The FASEB Journal. 33(2). 2171–2186. 28 indexed citations
11.
Kim, Bong‐Sung, Pathricia V. Tilstam, Corinna Schmitz, et al.. (2017). Characterization of adipose tissue macrophages and adipose-derived stem cells in critical wounds. PeerJ. 5. e2824–e2824. 12 indexed citations
12.
Tilstam, Pathricia V., Dake Qi, Lin Leng, Lawrence H. Young, & Richard Bucala. (2017). MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics. Expert Opinion on Therapeutic Targets. 21(7). 671–683. 61 indexed citations
13.
Kim, Bong‐Sung, Pathricia V. Tilstam, Soo Seok Hwang, et al.. (2016). D‐dopachrome tautomerase in adipose tissue inflammation and wound repair. Journal of Cellular and Molecular Medicine. 21(1). 35–45. 23 indexed citations
14.
Yoo, Seung‐Ah, Lin Leng, Bum‐Joon Kim, et al.. (2016). MIFallele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 113(49). E7917–E7926. 61 indexed citations
15.
Lehrke, Michael, Florian Kahles, Anna Makowska, et al.. (2015). PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner. Journal of Molecular and Cellular Cardiology. 81. 23–33. 32 indexed citations
16.
Tilstam, Pathricia V., Marion J. Gijbels, Mohamed Habbeddine, et al.. (2014). Bone Marrow-Specific Knock-In of a Non-Activatable Ikkα Kinase Mutant Influences Haematopoiesis but Not Atherosclerosis in Apoe-Deficient Mice. PLoS ONE. 9(2). e87452–e87452. 12 indexed citations
17.
Döring, Yvonne, Heidi Noels, Manuela Mandl, et al.. (2014). Deficiency of the Sialyltransferase St3Gal4 Reduces Ccl5-Mediated Myeloid Cell Recruitment and Arrest. Circulation Research. 114(6). 976–981. 47 indexed citations
18.
Noels, Heidi, Pathricia V. Tilstam, Wendy Theelen, et al.. (2014). Deficiency of Endothelial Cxcr4 Reduces Reendothelialization and Enhances Neointimal Hyperplasia After Vascular Injury in Atherosclerosis-Prone Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(6). 1209–1220. 51 indexed citations
19.
Asare, Yaw, Erdenechimeg Shagdarsuren, Johannes A. Schmid, et al.. (2013). Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thrombosis and Haemostasis. 110(7). 141–152. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026